Single Use Technologies (SUT) in Pharmaceutical Manufacturing
AI in Pharmaceutical Manufacturing Operations
The Increasing Importance of Manufacturability in API Development
Antibody + Drug + Third Party, Antibody + siRNAASO + Third Party
Redefining RNA Manufacturing Through Innovation in Biocatalysis
EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Beyond the Chiral Blind Spot: Agentic AI and the Future of Stereochemistry-Aware Drug Discovery
Artificial intelligence AI is rapidly changing pharmaceutical research From target identification and literature analysis to molecular design and biological prediction AI is becoming an increasingly important research partner Generative AI has accelerated molecular ideation and expanded the chemical space scientists can explore
-
Techno Trends
FDA Authorises Aletta for Autonomous Blood Collection
The US Food and Drug Administration FDA has authorised Aletta the first standalone robotic device designed to collect blood from a patients arm without handson operator intervention
-
Projects
Cambrex Expands Milan R&D Operations With US$30 Million Investment
Cambrex has begun construction of a new research and development facility at its Profarmico Milano site in Italy supported by a US million investment The initiative is designed
-
Research Insights
Dipteran flight diversity is shaped by aerodynamic constraints, scaling, and evolutionary trade-offs
Flight has been a key innovation in insect evolution yet the selective and mechanistic pressures shaping their flight motor systems remain poorly understood Here we present a comprehensive comparative analysis of flight in Diptera true flies integrating morphology wingbeat kinematics
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Vectorizing Hope: The Art and Science of Gene Therapy Vector Manufacturing
Kate Williamson
Gene therapy vector manufacturing is a dynamic field merging art and science to address genetic disorders. It involves precise vector design, production, and quality control. Challenges like safety an...
-
2
AI in Pharmacovigilance: The Dawn of a Data-Driven Safety Revolution
Dr. S. Neelufar Shama
Pharmacovigilance is the cornerstone of drug safety monitoring. It also faces challenges like vast data volumes, diverse information sources and need for rapid and accurate signal detection. The advan...
-
3
Foundation Models in Drug Discovery: The Next Frontier of Pharmaceutical Research
Lakshmi
Foundation models pretrained on vast biological corpora are replacing the one-model-per-task economics that has long limited computational drug discovery. This article explains what makes these system...
-
4
How American Pharma Companies are Addressing Global Health Challenges?
Kate Williamson
America boasts of several pharmaceutical industries that are very vital in meeting the world’s health needs, research, collaborations, and other advanced technologies in the health sector. Provi...
-
5
Digital Transformation in Pharma: Integrating AI & Automation Technologies
Lakshmi
Artificial intelligence and automation have moved from the pharmaceutical innovation fringe to the operating core, yet most organisations remain stranded between promising pilots and enterprise return...
press releasesRead more...
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia
Lkahi Therapeutics a subsidiary of Glucotrack Inc Nasdaq GCTK today announced the continued participation of the University of Georgias Student Industry Fellows Program in the ai Futures Lab
Scholar Rock Receives FDA Fast Track Designation for Apitegromab Facioscapulohumeral Muscular Dystrophy (FSHD) Program as Participant Dosing Commences in Phase 2 FORGE Trial
Scholar Rock NASDAQ SRRK a global biopharmaceutical company dedicated to improving the lives of patients with rare severe and debilitating neuromuscular diseases by applying its worldleading platform
United Therapeutics Corporation Announces FDA Acceptance of Supplemental New Drug Application for Nebulized Tyvaso® to Treat Idiopathic Pulmonary Fibrosis
United Therapeutics Corporation Nasdaq UTHR a public benefit corporation today announced that the FDA has accepted the supplemental New Drug Application sNDA for nebulized Tyvaso treprostinil
DnaK Therapeutics & GATC Health Forge A Partnership To Evaluate, Accelerate & Prioritize Cancer Drug Candidates Using AI Platform
DnaK Therapeutics and GATC Health Corp jointly announced today a collaboration to use GATCs proprietary artificial intelligence platform to evaluate and prioritize innovative potential cancer drug candidates
Events Read more...
03 - 05
Sep 20265th MENA Congress for Rare Diseases 2026
Beach Rotana Hotel, Abu Dhabi,...
09 - 10
Sep 2026iPSC Drug Development Summit
Hyatt Regency Boston Harbour,...
14 - 16
Sep 202614 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
15 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
LATEST NEWSRead more...
EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction
EpiVax Inc has launched AIenhanced features for ISPRI its in silico platform for assessing the immunogenicity risk of biotherapeutics The update includes an improved JanusMatrix model
Thermo Fisher Scientific Launches Multiskan™ Ease Absorbance Microplate Reader
Thermo Fisher Scientific has launched the Thermo Scientific Multiskan Ease Absorbance Microplate Reader designed to simplify routine laboratory analysis involving proteins cells and microorganisms
Juniper Biosciences Receives FDA Breakthrough Therapy Designation for JBS-003
Juniper Biosciences has received Breakthrough Therapy Designation from the US Food and Drug Administration FDA for JBS Ffluoromisonidazole or FMISO a hypoxia tracer being developed to guide reduced radiation therapy in patients with HPVpositive oropharyngeal carcinoma OPC
FDA approves PharmaEssentia’s BESREMi for adults with essential thrombocythaemia
PharmaEssentia USA Corporation a subsidiary of PharmaEssentia Corporation has received approval from the US Food and Drug Administration FDA for BESREMi ropeginterferon alfabnjft to treat adults with essential thrombocythaemia ET a rare form of blood cancer
Transcat expands biomedical calibration business with Southeastern Biomedical acquisition
Transcat Inc has acquired privately held Southeastern Biomedical Associates Incorporated strengthening its biomedical calibration services and expanding its presence across the southeastern United States
FDA Approves Revolution Medicines’ RASONQUE for Metastatic Pancreatic Cancer
The US Food and Drug Administration FDA has approved Revolution Medicines RASONQUE daraxonrasib tablets for adults with metastatic pancreatic adenocarcinoma PDAC who have received at least one previous systemic treatment or are not candidates for multiagent systemic therapy
